DLD Asset Management’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-94,853
Closed -$1M – 489
2026
Q1
$1M Hold
94,853
– – 0.09% 162
2025
Q4
$995K Hold
94,853
– – 0.07% 193
2025
Q3
$982K Sell
94,853
-100,000
-51% -$1.03M 0.07% 176
2025
Q2
$2M Hold
194,853
– – 0.17% 98
2025
Q1
$1.96M Buy
+194,853
New +$1.96M 0.15% 72

Other funds holding TDAC

DLD Asset Management's TDAC Position: Q2 2026 in Review

DLD Asset Management sold out of Translational Development Acquisition Corp (TDAC) in Q2 2026, closing a stake of 94,853 shares — an estimated $1M sold.

DLD Asset Management first reported a position in TDAC in Q1 2025 and held it in 5 quarters. The position peaked at $2M in Q2 2025. 35 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

  • DLD Asset Management reported no remaining Translational Development Acquisition Corp position as of Q2 2026 after selling out during the quarter.
  • DLD Asset Management sold 94,853 Translational Development Acquisition Corp shares in Q2 2026, an estimated $1M.
  • DLD Asset Management first reported a position in Translational Development Acquisition Corp in Q1 2025 and held it in 5 quarters.
  • DLD Asset Management's Translational Development Acquisition Corp position peaked at $2M in Q2 2025.
  • 35 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on DLD Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.